Blood Screening Market Trends and Forecast: Examining Growth Opportunities
The global blood screening market is experiencing remarkable growth, driven by a rising prevalence of infectious diseases, an expanding geriatric population, and increased blood donation programs and transfusions. However, challenges such as the lack of standardization, complex regulatory approval processes, and a shortage of skilled personnel hinder the market’s expansion, particularly in developing economies.
Infectious Disease Screening and Prenatal Testing Remain Key Growth Factors
The mandatory screening of donated blood for infectious agents such as HIV, hepatitis viruses, syphilis, and others remains a significant driver of the global blood screening market. Emerging opportunities in microbiology screening and multiplexing, as well as pathogen reduction technology, are expected to further boost market growth. Additionally, prenatal testing for abnormalities during pregnancy and the use of advanced techniques like western blot assay, next-generation sequencing (NGS), and enzyme-linked immunosorbent assay (ELISA) contribute to the market’s flourishing prospects.
COVID-19 Pandemic Creates New Avenues for Growth
While the blood screening sector initially faced challenges during the COVID-19 pandemic, it has ultimately benefitted from the crisis. Initiatives such as blood screening for COVID-19 antibodies by organizations like the American Red Cross, along with mandatory screening of donated plasma, have bolstered market growth. The FDA’s emergency use authorization for serological tests and the encouragement of plasma donation have also played significant roles in sustaining the market.
Blood Banks and NAT Technology Lead the Way
Blood banks and hospitals are among the top end-users of blood screening tests, with reagents and kits as the most sought-after products due to their accessibility and need for reliable detection of transfusion-transmissible infections. Nucleic acid amplification tests (NAT) are expected to remain the preferred screening technology due to their high specificity and sensitivity for viral nucleic acids.
Strong Growth in Developed Western Regions and Emerging Markets
North America and Europe are expected to dominate the blood screening market, driven by high demand for blood donation initiatives and the prevalence of chronic and infectious diseases. The Asian Pacific region presents new growth opportunities, thanks to government initiatives and increased awareness of disease transmission through blood transfusion.
Recent Developments Highlighting Innovation in Blood Screening
Recent advancements in blood screening include AI-enabled tests for early lung cancer detection, rapid screening for placenta accreta spectrum disorder in pregnancy, multi-cancer blood tests capable of detecting over 50 types of cancers, and a novel blood screening test for prostate cancer that reduces unnecessary MRI scans.
Challenges in Blood Test Supplies
NHS England has faced challenges due to a shortage of blood screening test tubes and vials, leading to delays in patient care delivery.
Key Players in the Global Blood Screening Market
Prominent companies in the blood screening market include GE Healthcare, Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Perkinelmer, Grifols, S.A., Ortho Clinical Diagnostics, Inc., and others.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/blood-screening-market
Visit Our Blogs:
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad